Business Wire

GWI Launches New Office in Singapore, Expands APAC Footprint

Share

GWI, the leading target audience company, today announces the opening of its first APAC office this October in Singapore.

Currently headquartered in London with offices in New York, Prague and Athens, the new Singapore office will position GWI as leading providers of world class research capabilities and solid insights to companies in the APAC region.

Tom Smith, CEO and Founder of GWI explains: “We are powering a world where every business knows its audience. We need to build our presence on the ground in the Asia Pacific to take advantage of the region’s rapidly growing business opportunities. APAC currently represents 20% of our accounts, worth £1.275bn, and has the largest compound annual growth rate (CAGR). Since 2017, APAC has experienced the fastest growth of any region with CAGR in excess of 35%.

“What’s more, our own data* tells us that 71% of professionals in APAC agree that being able to adapt quickly is critical to their company’s long term success. Over a third (34%) of decision-makers in APAC say that keeping up with the latest trends is one of their main considerations for bringing in a new product or service. So we know the businesses in the region are in need of fresh data to help them make critical decisions, and by setting up an office in the region we can enable them to focus on what matters, find the best ideas and then make them happen.

“What’s more, over a third (37%)* of professionals in APAC say that understanding their customer or client audience is one of the biggest challenges their company faces, making it their fourth biggest challenge out of a list of about 25 challenges. This really highlights the need for robust, reliable consumer data. Interestingly, this is highest among business professionals in India and Singapore. Creating a presence on the ground will therefore help us to stay ahead of the ever-changing needs of our customers operating in the region.”

Singapore is well positioned to act as a launchpad for high growth, low penetration markets such as China, Japan and Australia. GWI already works extensively with businesses in the APAC region, especially New Zealand and Australia.

Tom continues: “Significantly, we are increasingly asked for local support by some of our biggest clients, from independent agencies to corporate brands. We therefore decided this is the perfect time to expand our company and open an office in Singapore. By putting a team in Singapore, we will be able to overcome any language, cultural, network and timezone challenges whilst accelerating APAC growth.”

The APAC office will initially be staffed by a combination of relocated European team members and locally sourced talent. The open job positions can be viewed here. The expansion into APAC will allow GWI to realise continued growth in the years to come following its successes in 2020 where the company signed over 200 new enterprise customers and posted more than 40% growth in annual recurring revenue.

ENDS

Notes to editors

*Source: Q2 2020 Wave of GWI Work data

About GWI

GWI is the leading supplier of target audience insight to the global marketing industry.

Trusted by the world’s biggest brands, media organizations, and agencies on a daily basis to get closer to their audiences, the company’s flagship survey represents over 2 billion people globally. Using the subscription-based platform, clients like Twitter, Google, Spotify, WPP, IPG, and Omnicom Group gather in-depth insights into behaviors, attitudes, and interests in seconds through a combination of survey data and analytics.

Among a range of leading data products available alongside its flagship survey are:

- GWI USA is a deep dive into the habits, behaviors and attitudes of 240m internet users in the USA.

- GWI Gaming delves into the actions and attitudes of gamers across 15 markets.

- GWI Sports investigates sports fandom and participation across 15 markets.

- GWI Kids gets to the heart of how kids actually think, so you can be sure to kid-proof your ideas and concepts from here on.

- GWI Work gives a detailed view of the lives of business professionals across 10 markets.

- GWI Zeitgeist, included with our core survey, is fielded monthly and zeroes in on the stuff that matters. It’s topical, timely, and relevant.

Those looking for even more bespoke research solutions can enrich GWI data with a range of services like hyper-targeted custom surveys, brand trackers, and recontact studies.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press:
Liam Rawson
Hotwire Global
gwi@hotwireglobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release

Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release

Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release

AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by

illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye